Two blood tests can predict which subset of men with advanced prostate cancer will likely not benefit from anti-androgen therapies, providing doctors and patient added clarity on treatment options, ...

Stanford Health Care delivers the highest levels of care and compassion. SHC treats cancer, heart disease, brain disorders, primary care issues, and many more.

Researchers from The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust have worked to together to develop a type of blood test that can identify which men with advanced prostate ...

Scientists have found a possible new way to make some advanced prostate cancers more vulnerable to the immune system. The experimental strategy combines the targeted cancer drug olaparib with ...

Advanced prostate cancer used to mean a short list of options and a difficult conversation. That’s changed substantially. There are more effective treatments now than there were five years ago, ...

I know prostate cancer is common, but I’m not sure who is most at risk or whether there are symptoms to watch for. When ...

Learn what prostate cancer survival rates say about treatment effectiveness and life expectancy, and the importance of early detection through screening.

CHICAGO -- Patients with advanced prostate cancer treated with enzalutamide (Xtandi) had a significantly greater decline in cognitive function compared with those who received darolutamide (Nubeqa), ...

A test that costs less than a $1 and yields results in minutes has been shown in newly published studies to be more sensitive and more exact than the current standard test for early-stage prostate ...